KetoSwiss is a Swiss biotechnology start-up that specializes in the development of brain fuels for neurological diseases. They offer both nutraceuticals and pharmaceuticals, with a focus on treating migraines using their product called MigraKet. The active substance in MigraKet is an endogenous metabolite known as a ketone body, which the brain can use as an alternative fuel to glucose when glucose utilization is compromised.

In addition to migraine treatment, KetoSwiss aims to expand their portfolio to address other neurological diseases such as Alzheimer's Disease. They are dedicated to combatting the energy deficiency in the brain caused by modern carbohydrate-rich diets, which contributes to the development of various neurological conditions. At KetoSwiss, they strive to develop potent and clinically tested ketone body products of exceptional Swiss quality.

Their products are science-based and free from additives, offering clean and simple solutions. KetoSwiss is committed to improving brain health globally and prioritizes creating a fulfilling and values-based corporate culture. They emphasize innovation, quality, passion, loyalty, and trust in all aspects of their business